Literature DB >> 11316993

Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients.

M Nebuloni1, A Pellegrinelli, A Ferri, S Bonetto, R Boldorini, L Vago, M P Grassi, G Costanzi.   

Abstract

OBJECTIVES: To evaluate the correlation between immunohistochemical positive patterns (globular and filamentous structures) of beta-amyloid precursor protein (beta-APP), used as a marker of axonal damage, and the different distribution of HIV p24 antigens, in three different brain areas of AIDS patients.
METHODS: Eighteen AIDS patients with HIV-related brain lesions were included in the study. Forty-nine sections from basal ganglia, frontal cortex and hippocampus were selected. After microwave oven pre-treatment, the sections were incubated with anti-HIV p24 and anti-beta-APP monoclonal antibodies; the reactions were developed with peroxidase/3,3'diaminobenzidine. The positivity was graded by semi-quantitative scores. Double immunohistochemical staining was used to evaluate the co-localization of the antigens.
RESULTS: HIV p24 immunohistochemistry was positive in 44 of 49 sections (89%), with a prevalence of interstitial positive cells and positive microglial nodules in 27 and 13 sections respectively. beta-APP-positive structures were demonstrated in 23 of 44 sections (52%) with HIV-related lesions, and were absent from the five sections without viral expression. Globular and filamentous lesions were observed in 21 of 23 sections and 10 of 23 lesions respectively. Moreover, a high grade of globular type lesion was related to an elevated presence of diffuse interstitial HIV p24-positive cells in basal ganglia; double immunohistochemical reactions demonstrated the co-localization of beta-APP globules and HIV p24 antigens.
CONCLUSIONS: The data obtained confirm the coexpression of beta-APP and viral antigens in particular areas of the brain with HIV-related lesions; there is a strict correlation between beta-APP globules (indicating chronic cerebral damage) and the interstitial pattern of HIV p24 immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316993     DOI: 10.1097/00002030-200103300-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  26 in total

1.  Platelet decline as a predictor of brain injury in HIV infection.

Authors:  Ann B Ragin; Gypsyamber D'Souza; Sandra Reynolds; Eric Miller; Ned Sacktor; Ola A Selnes; Eileen Martin; Barbara R Visscher; James T Becker
Journal:  J Neurovirol       Date:  2011-09-29       Impact factor: 2.643

Review 2.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

3.  Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.

Authors:  Magnus Gisslén; Jan Krut; Ulf Andreasson; Kaj Blennow; Paola Cinque; Bruce J Brew; Serena Spudich; Lars Hagberg; Lars Rosengren; Richard W Price; Henrik Zetterberg
Journal:  BMC Neurol       Date:  2009-12-22       Impact factor: 2.474

4.  Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  Clin Res HIV AIDS       Date:  2014-08-31

Review 5.  The three human monocyte subsets: implications for health and disease.

Authors:  Kok Loon Wong; Wei Hseun Yeap; June Jing Yi Tai; Siew Min Ong; Truong Minh Dang; Siew Cheng Wong
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 6.  Fate of microglia during HIV-1 infection: From activation to senescence?

Authors:  Natalie C Chen; Andrea T Partridge; Christian Sell; Claudio Torres; Julio Martín-García
Journal:  Glia       Date:  2016-11-26       Impact factor: 7.452

Review 7.  Role of HIV in amyloid metabolism.

Authors:  Mario Ortega; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-10       Impact factor: 4.147

8.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

9.  Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.

Authors:  Cristian L Achim; Anthony Adame; Wilmar Dumaop; Ian P Everall; Eliezer Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-17       Impact factor: 4.147

10.  Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production.

Authors:  Xuesong Chen; Liang Hui; Nicholas H Geiger; Norman J Haughey; Jonathan D Geiger
Journal:  Neurobiol Aging       Date:  2013-05-11       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.